Expansion of hematopoietic stem/progenitor cells

American Journal of Hematology

Volumn 83, Issue 12, 2008, Pages 922-926

  Wu, Hai Jiang ^a   Deng, Xin Na ^a   Duan, Hui Jun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TELOMERASE;

BIOREACTOR; BONE MARROW CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CHROMATIN; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL EXPANSION; TRANSCRIPTION REGULATION;

BIOREACTORS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CLINICAL TRIALS AS TOPIC; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 56749136239     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21262     Document Type: Review

References (69)

1. Cohena Y, Nagler A. Hematopoietic stem-cell transplantation using umbilical-cord blood. Leuk Lymphoma 2003;44:1287-1299.
2. Gluckman E. Hematopoietic stem-cell transplants using umbilical-cord blood. N Engl J Med 2001;344:1860-1861.
3. Gong W, Mei X-G, Wang H. Advance in ex vivo expansion of hematopoietic stem/progenitor cells. Biomed Engineering Foreign Med Sci 2005;28:257-261.
4. Piacibello W, Sanavio F, Garetto L, et al. Extensive amplification and self-renewal of human primitive haematopoietic stem cells from cord blood. Blood 1997;89:2644-2653.
5. Gammaitoni L, Bruno S, Sanavio F, et al. Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp Hematol 2003;31:261-270.
6. Srour EF, Abonour R, Cornetta K, et al. Ex vivo expansion of hematopoietic stem and progenitor cells: Are we there yet? J Hematother 1999;8:93-102.
7. Jang YK, Jung DH, Jung MH, et al. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 2006;85:212-225.
8. Li K, Lee SM, Su RJ, et al. Multipotent neural precursors express neural and hematopoietic factors, and enhance ex vivo expansion of cord blood CD341 cells, colony forming units and NOD/SCID-repopulating cells in contact and noncontact cultures. Leukemia 2005;19:91-97.
9. Rosler E, Brandt J, Chute J, et al. Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD341CD38- cells. Exp Hematol 2000;28:841-852.
10. Hu L, Cheng L, Wang J, et al. Effects of human yolk sac endothelial cells on supporting expansion of hematopoietic stem/progenitor cells from cord blood. Cell Biol Int 2006;30:879-884.
11. Yildirim S, Boehmler AM, Kanz L, et al. Expansion of cord blood CD341 hematopoietic progenitor cells in co-culture with autologous umbilical vein endothelial cells (HUVEC) is superior to cytokine-supplemented liquid culture. Bone Marrow Transplant 2005;36:71-79.
12. Ahmed N, Khokher MA, Hassan HT. Cytokine-induced expansion of human CD341 stem/progenitor and CD341 CD411 early megakaryocytic marrow cells cultured on normal osteoblasts. Stem Cells 1999;17:92-99.
13. Madihally SV, Flake AW, Matthew HW. Maintenance of CD34 expression during proliferation of CD341 cord blood cells on glycosaminoglycan surfaces. Stem Cells 1999;17:295-305.
14. Feugier P, Jo DY, Shieh JH, et al. Ex vivo expansion of stem and progenitor cells in co-culture of mobilized peripheral blood CD341 cells on human endothelium transfected with adenovectors expressing thrombopoietin, c-kit ligand, and Flt-3 ligand. Hematother Stem Cell Res 2002;11:127-138.
15. Nishioka K, Fujimori Y, Hashimoto-Tamaoki T, et al. Immortalization of bone marrow-derived human mesenchymal stem cells by removable simian virus 40T antigen gene: Analysis of the ability to support expansion of cord blood hematopoietic progenitor cells. Int J Oncol 2003;23:925-932.
16. Kawano Y, Kobune M, Yamaguchi M, et al. Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a co-culture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells. Blood 2003;101:532-540.
17. Kobune M, Ito Y, Kawano Y, et al. Indian hedgehog gene transfer augments hematopoietic support of human stromal cells including NOD/SCID-beta2m-/- repopulating cells. Blood 2004;104:1002-1009.
18. Xie CG, Wang JF, Xiang Y, et al. Marrow mesenchymal stem cells transduced with TPO/FL genes as support for ex vivo expansion of hematopoietic stem/progenitor cells. Cell Mol Life Sci 2005;62:2495-2507.
19. Xu ZS, Liu YJ, Lv LL, et al. Bone marrow stromal cells transduced with human hemangiopoietin gene support hematopoiesis in vitro. Haematologica 2005;90:157-165.
20. Xie C, Jia B, Xiang Y, et al. Support of hMSCs transduced with TPO/FL genes to expansion of umbilical cord CD341 cells in indirect co-culture. Cell Tissue Res 2006;326:101-110.
21. Nakajima H, Shibata F, Fukuchi Y, et al. Immune suppressor factor confers stromal cell line with enhanced supporting activity for hematopoietic stem cells. Biochem Biophys Res Commun 2006;340:35-42.
22. Xie CG, Wang JF, Xiang Y, et al. Cocultivation of umbilical cord blood CD341 cells with retro-transduced hMSCs leads to effective amplification of long-term culture-initiating cells. World J Gastroenterol 2006;12:393-402.
23. Sugimoto A, Yamamoto M, Suzuki M, et al. Delta-4 Notch ligand promotes erythroid differentiation of human umbilical cord blood CD34D cells. Exp Hematol 2006;34:424-432.
24. Han JY, Goh RY, Seo SY, et al. Cotransplantation of cord blood hematopoietic stem cells and culture-expanded and GM-CSF-/SCF-transfected mesenchymal stem cells in SCID mice. J Korean Med Sci 2007;22:242-247.
25. Jang YK, Jung DH, Jung MH, et al. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 2006;85:212-225.
26. Palsson BO, Paek SH, Schwartz RM, et al. Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system. Biotechnology 1993;11:368-372.
27. Meissner P, Schroder B, Herfurth C, et al. Development of a fixed bed bioreactor for the expansion of human hematopoietic progenitor cells. J Cytotechnol 1999;30:227-234.
28. Liu Y, Liu T, Fan X, et al. Ex vivo expansion of hematopoietic stem cells derived from umbilical cord blood in rotating wall vessel. J Biotechnol 2006;124:592-601.
29. Chi ZY, Jiang H, Cai HB, et al. Perfusion culture of hematopoietic cells in a stirred tank bioreactor. Sheng Wu Gong Cheng Xue Bao 2005;21:622-627 (in Chinese).
30. Thorsteinsdottir U, Sauvageau G, Humphries RK. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size. Blood 1999;94:2605-2612.
31. Antonchuk J, Sauvageau G, Humphries RK. HOXB4-induced expansion of adult hematopoietic stem cell ex vivo. Cell 2002;109:39-45.
32. Zhang XB, Beard BC, Beebe K, et al. Differential effects of HOXB4 on nonhuman primate short- and long-term repopulating cells. PLoS Med 2006;3:e173.
33. Tanaka H, Matsumura I, Itoh K, et al. HOX decoy peptide enhances the ex vivo expansion of human umbilical cord blood CD341 hematopoietic stem cells/hematopoietic progenitor cells. Stem Cells 2006;24:2592-2602.
34. Milsom MD, Duxbury R, Gagen D, et al. Overexpression of HOXB4 confers a myelo-erythroid differentiation delay in vitro. Leukemia 2005;19:148-153.
35. Thorsteinsdottir U, Sauvageau G, Hough MR, et al. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol 1997;17:495-505.
36. Fischbach NA, Rozenfeld S, Shen W, et al. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. Blood 2005;105:1456-1466.
37. Thorsteinsdottir U, Mamo A, Kroon E, et al. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 2002;99:121-129.
38. Kim HG, de Guzman CG, Swindle CS, et al. The ETS family transcription factor PU. 1 is necessary for the maintenance of fetal liver hematopoietic stem cells. Blood 2004;104:3894-3900.
39. Zhang P, Behre G, Pan J, et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU. 1. Proc Natl Acad Sci USA 1999;96:8705-8710.
40. Sandberg ML, Sutton SE, Pletcher MT, et al. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 2005;8:153-166.
41. Grana X, Reddy EP. Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995;11:211-219.
42. Yuan Y, Shen H, Franklin DS, et al. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat Cell Biol 2004;6:436-442.
43. Cheng T. Cell cycle inhibitors in normal and tumor stem cells. Oncogene 2004;23:7256-7266.
44. Kurita-Ochiai T, Hashizume T, Yonezawa H. Characterization of the effects of butyric acid on cell proliferation, cell cycle distribution and apoptosis. FEMS Immunol Med Microbiol 2006;47:67-74.
45. Ito K, Hirao A, Arai F, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004;431:997-1002.
46. Li J, Xie C, Xie X-Y, et al. Regulatory role of HTm4 gene in hematopoietic cell cycle. Acta Physiol Sin 2004;57:188-192.
47. Wang S, Zhang Y, Soosairajah J, et al. Regulation of RUNX1/AML1 during the G2/M transition. Leuk Res 2007;31:839-851.
48. Walz C, Crowley BJ, Hudon HE, et al. Activated Jak2 with the V617F point mutation promotes G1/S phase transition. J Biol Chem 2006;281:18177-18183.
49. Li J, Sejas DP, Rani R, et al. Nucleophosmin regulates cell cycle progression and stress response in hematopoietic stem/progenitor cells. J Biol Chem 2006;281:16536-16545.
50. Ghiaur G, Lee A, Bailey J, et al. Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftment. Blood 2006;108:2087-2094.
51. Vishalakumar S, Patel H, Moharita AL, et al. The anti-proliferative effect of neurokinin-A on hematopoietic progenitor cells is partly mediated by p53 activating the 50 flanking region of neurokinin-2 receptor. Cell Signal 2006;18:422-432.
52. Roy S, Ingham PW. Hedgehogs tryst with the cell cycle. J Cell Sci 2002;115:4393-4397.
53. Vaziri H, Dragowska W, Allsopp RC, et al. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91:9857-9860.
54. Burns JS, Abdallah BM, Guldberg P, et al. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res 2005;65:3126-3135.
55. Milhem M, Mahmud N, Lavelle D, et al. Modification of hematopoietic stem cell fate by 5aza 20 deoxycytidine and trichostatin A. Blood 2004;103:4102-4110.
56. Araki H, Mahmud N, Milhem M, et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. Exp Hematol 2006;34:140-149.
57. Araki H, Yoshinaga K, Boccuni P, et al. Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood 2007;109:3570-3578.
58. De Felice L, Tatarelli C, Mascolo MG, et al. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res 2005;65:1505-1513.
59. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 2003;101:5061-5067.
60. Pecora AL, Stiff P, Jennis A, et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant 2000;25:797-799.
61. McNiece I, Jones R, Bearman SI, et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000;96:3001-3007.
62. Shpall EJ, Quinones R, Giller R, et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-376.
63. Rubio D, Garcia-Castro J, Martin MC, et al. Spontaneous human adult stem cell transformation. Cancer Res 2005;65:3035-3039.
64. Wang Y, Huso DL, Harrington J, et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 2005;7:509-519.
65. Osawa M, Hanada K, Hanada H, et al. Long-term lymphohematopoietic reconstrution by a single CD34-1ow/negatic hematopoietic stem cell. Science 1996;273:242-245.
66. Morel F, Galy A, Chen B, et al. Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34- fractions of Thy-1lowLin-/lowSca-1+ bone marrow cells. Exp Hematol 1998;26:440-448.
67. Hess DA, Karanu FN, Levac K, et al. Co-culture and transplant of purified CD34 (+)Lin(-) and CD34(-)Lin(-) cells reveals functional interaction between repopulating hematopoietic stem cells. Leukemia 2003;17:1613-1625.
68. Horn PA, Kiem HP. Expansion of SCID repopulating cells does not prove expansion of hematopoietic stem cells. Blood 2006;108:771.
69. Tatekawa T, Ogawa H, Kawakami M, et al. A novel direct competitive repopulation assay for human hematopoietic stem cells using NOD/SCID mice. Cytotherapy 2006;8:390-398.